Researchers at BYU have devised a system to speed up the process of making life-saving vaccines for new viruses.
Their concept is to create the biological machinery for vaccine production en masse, put it in a freeze-dried state and stockpile it around the country. Then, when a new virus hits, labs can simply add water to a “kit” to rapidly produce vaccines.
“You could just pull it off the shelf and make it,” said senior author Brad Bundy, associate professor of chemical engineering. “We could make the vaccine and be ready for distribution in a day.”
The research, published in Biotechnology Journal, demonstrates the ability to store the drug and vaccine-making machinery for more than a year.
Traditional systems to produce vaccines for pandemic influenza strains require heavy engineering and specialized equipment that only a few labs across the country have on hand. These traditional systems are also time-consuming, taking months to execute.
Bundy’s idea is a new angle on the emerging method of “cell-free protein synthesis,” a process that combines DNA to make proteins needed for drugs (instead of growing protein in a cell). His lab is creating a system where the majority of the work is done beforehand so vaccine kits can be ready to go and be activated at the drop of a dime.
“It will not only provide a quicker response to pandemics, but it will also make protein-based drugs more available to third-world countries where production and refrigerated storage can be problematic,” added William Pitt, a study coauthor and fellow BYU professor of chemical engineering.
While the team is now testing their version of the cell-free, recombinant DNA process for vaccine production, they’ve already successfully demonstrated it for at least one anti-cancer protein (onconase).
The researchers believe their method can significantly reduce investment of time and money towards future drug production and, in turn, reduce treatment expenses for patients.
“The drugs today are changing,” Bundy said. “The lifesaving cancer drugs we have now, the drugs for arthritis, the drugs with the greatest impact, are made out of proteins, not small chemical molecules. This method takes full advantage of that to provide a quicker, more personal response.”
The Latest on: Making vaccines
via Google News
The Latest on: Making vaccines
- Vaccine exemption rates among US kindergartners continue to climb, CDC sayson October 19, 2019 at 6:19 am
Nationally, among those vaccine-exempt kindergartners, only 0.3% had a medical exemption while 2.2% ... "Measles erupted in seven of those 14 counties, so we wound up making the first good measles ...
- Highly diluted candidate Ebola vaccine remains fully protective against disease in macaqueson October 18, 2019 at 4:05 pm
Even the macaques given the lowest dose appeared completely protected from disease due to EBOV. The scientists say their study findings could help make more vaccine available for more people and may ...
- What You Need to Know About Meningitis Vaccineson October 18, 2019 at 1:40 pm
The vaccine for meningococcal serotype B is the newest one on the market. It’s not included in the broader ACWY vaccine because it was a harder vaccine to make, Mukundan says. It’s currently ...
- Combating MERS in camels with a single-dose vaccineon October 18, 2019 at 10:15 am
Previous studies have shown that one dose of ChAdOx1-based vaccine is effective against Rift Valley fever in multiple species, including camels, making it a promising vaccine tool. The scientists ...
- India Conjugate Vaccine Market 2018 to 2023|Industry Outlook, Size and Forecaston October 18, 2019 at 7:42 am
India is one of the most prominent markets of conjugate vaccines.India is expected to be the fastest growing market due to the government's focus on research and development in the life sciences ...
- Pneumonia Vaccine Market Size, Future Forecast, Key Manufactures And Competitors Analysis, 2025 | GlaxoSmithKline, Pfizer, Merckon October 18, 2019 at 3:08 am
The research on the global Pneumonia Vaccine market offers an unbiased opinion of potential investments that players can make in the market. It also includes global market figures and potential CAGR.
- Delivery of flu vaccines for children, seniors delayed: Illinois Health Departmenton October 18, 2019 at 2:15 am
The IDH said the delay is due to the process of determining the strains included in this year's vaccine. The IDH believes the vaccine shipments should be fully delivered by the end of November. They ...
- Opponents of new vaccine law will get their shot at overturning it at the pollson October 17, 2019 at 7:45 pm
The Legislature passed the vaccine law in June, with the bill clearing the state ... But supporters of the new law said they would work to make sure voters reject the veto push. “We are confident that ...
- As 2019 Flu Season Nears, a One-Time Vaccine Could Be Available Soonon October 17, 2019 at 4:24 pm
Here is a look at the measles vs. the flu: &amp;amp;amp;amp;amp;amp;amp;nbsp; So if measles can be contained, so can the flu, according to Krammer. “If you could get these vaccination rates up ...
- CDC: Vaccine exemption rates among kindergartners continue to climbon October 17, 2019 at 2:35 pm
Nationally, among those vaccine-exempt kindergartners, only 0.3% had a medical exemption while 2.2% ... "Sure enough, measles erupted in seven of those 14 counties, so we wound up making the first ...
via Bing News